Drugs / Ad5-delta24RGD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00562003 | Jun 2007 → May 2009 | ovarian cancer, primary peritoneal carcinoma | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad5-delta24RGD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00562003 ↗ |
| Route | Other | “intraperitoneal delivery” NCT00562003 ↗ |